NEOVA DAY THERAPY, SPF 20
last updated: 02/12/10 brand: Neova by ProCyte Corporation
COMPANY POLICIES
Compact for Safe Cosmetics
|
Animal Testing Policy |
Buy on Amazon, Support EWG!
Sunscreen effectiveness* breakdown
| MEDIUM | UVB sunburn protection |
| MEDIUM | UVA protection |
| HIGH | sunscreen stability |
*Note that the same active ingredient combination may score differently in two different products depending on the concentration of the ingredients and the mixture of inactive ingredients.
Active ingredient UV |
 | ||||||||||||||||||||||||||||||||||||
 Product total |
| ||||||||||||||||||||||||||||||||||||
| OCTINOXATE (OCTYL METHOXYCINNAMATE) (7.5%) |
| ||||||||||||||||||||||||||||||||||||
| OCTISALATE (5%) |
| ||||||||||||||||||||||||||||||||||||
| NANO ZINC OXIDE (20-60nm) (2%) |
| ||||||||||||||||||||||||||||||||||||
Skin Deep has multiple formulations for this product in the database.
Please read the ingredients carefully.
See formulation: | 1 | 2 |
Note to manufacturers: We have assumed a typical particle size for the mineral(s) in your product based on typical industry use. We welcome specific data from manufacturers if actual particle size is different.
Given the incomplete information made available by companies and the government, EWG provides additional information on personal care product ingredients from the published scientific literature. The chart below indicates that research studies have found that exposure to one or more ingredients in this product -- not the product itself -- caused the indicated health effect(s) in the studies reviewed by Skin Deep researchers. Actual health risks, if any, will vary based on the level of exposure to the ingredient and individual susceptibility -- information not available in Skin Deep.
Ingredients in this product are linked to: | |
 | Cancer |
 | Developmental/reproductive toxicity |
| Violations, restrictions & warnings |
| Allergies/immunotoxicity |
| Other concerns for ingredients used in this product: Neurotoxicity, Endocrine disruption, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Multiple, additive exposure sources, Irritation (skin, eyes, or lungs), Enhanced skin absorption, Contamination concerns, Occupational hazards, Biochemical or cellular level changes |
Ingredients from packaging: OCTINOXATE 7.5%, OCTISALATE 5%, ZINC OXIDE 2%, WATER, GLYCERIN, CETEARYL ALCOHOL, GLYCERYL STEARATE, PEG-100 STEARATE, POLYACRYLAMIDE, C13-14 ISOPARAFFIN, LAURETH-7, PREZATIDE COPPER ACETATE, ARGININE, PANTHENOL, DIMETHICONE, TOCOPHEROL ACETATE, SQUALANE, BHT, POLYSORBATE 20, XANTHAN GUM, PHENOXYETHANOL, MEHTYLPARABEN, ETHYLPARABEN, BUTYLPARABEN, PROPYLPARABEN, ISOBUTYLPARABEN, ULTRAMARINES.
Directions from packaging: Apply liberally to face and neck in the morning.
user reviews & comments
NEW! No reviews or ratings yet. Log in and be the first to leave a comment!
ingredients
| score | data gap | concerns | |
| METHYLPARABEN MEHTYLPARABEN | 10 | 63% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Biochemical or cellular level changes |
| NANO ZINC OXIDE (20-60nm) (Active Ingredient) | 3 | 70% | Violations, restrictions & warnings, Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Occupational hazards |
| OCTINOXATE (OCTYL METHOXYCINNAMATE) (Active Ingredient) | 8 | 65% | Violations, restrictions & warnings, Endocrine disruption, Allergies/immunotoxicity, Persistence and bioaccumulation, Enhanced skin absorption, Biochemical or cellular level changes |
| PEG-100 STEARATE | 4 | 69% | Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE, ETHYLENE OXIDE, 1,4-DIOXANE) |
| BUTYLPARABEN | 6 | 79% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Biochemical or cellular level changes |
| BHT | 6 | 61% | Neurotoxicity, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards, Biochemical or cellular level changes |
| ETHYLPARABEN | 5 | 80% | Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| PROPYLPARABEN | 5 | 71% | Developmental/reproductive toxicity, Endocrine disruption, Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| TOCOPHERYL ACETATE TOCOPHEROL ACETATE | 4 | 81% | Allergies/immunotoxicity, Contamination concerns (HYDROQUINONE) |
| OCTISALATE (Active Ingredient) | 3 | 68% | Violations, restrictions & warnings, Allergies/immunotoxicity, Irritation (skin, eyes, or lungs), Enhanced skin absorption |
| PHENOXYETHANOL | 4 | 67% | Violations, restrictions & warnings, Allergies/immunotoxicity, Organ system toxicity (non-reproductive), Irritation (skin, eyes, or lungs), Occupational hazards |
| LAURETH-7 | 3 | 100% | Contamination concerns (ETHYLENE OXIDE, 1,4-DIOXANE) |
| ISOBUTYLPARABEN | 3 | 83% | Allergies/immunotoxicity, Organ system toxicity (non-reproductive) |
| ARGININE | 3 | 79% | Neurotoxicity, Organ system toxicity (non-reproductive) |
| DIMETHICONE | 2 | 74% | Violations, restrictions & warnings |
| POLYACRYLAMIDE | 3 | 71% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive), Contamination concerns (ACRYLAMIDE) |
| ULTRAMARINES | 2 | 90% | Multiple, additive exposure sources |
| PANTHENOL | 2 | 88% | Multiple, additive exposure sources |
| GLYCERIN | 2 | 74% | Organ system toxicity (non-reproductive), Occupational hazards |
| C13-14 ISOPARAFFIN | 1 | 93% | none identified |
| CETEARYL ALCOHOL | 0 | 93% | none identified |
| SQUALANE | 1 | 93% | Irritation (skin, eyes, or lungs) |
| PREZATIDE COPPER ACETATE | 1 | 90% | Persistence and bioaccumulation, Organ system toxicity (non-reproductive) |
| GLYCERYL MONOSTEARATE GLYCERYL STEARATE | 1 | 88% | none identified |
| POLYSORBATE-20 | 1 | 84% | none identified |
| XANTHAN GUM | 0 | 94% | none identified |
| WATER | 0 | 0% | innocuous |
Cancer*
*This table includes all possible cancer concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more in vitro tests non-mammalian cells show positive mutation results | PHENOXYETHANOL | |
| One or more animal studies show tumor formation at moderate doses | PEG-100 STEARATE | |
| One or more in vitro tests on mammalian cells show positive mutation results | NANO ZINC OXIDE (20-60nm) | |
| One or more in vitro tests on mammalian cells show positive mutation results | TOCOPHERYL ACETATE, PROPYLPARABEN, METHYLPARABEN, GLYCERIN, ETHYLPARABEN, BUTYLPARABEN, ARGININE | |
| Cancer - not classifiable/not likely to be human carcinogen | BHT |
Developmental/reproductive toxicity*
*This table includes all possible developmental/reproductive toxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show reproductive effects at high doses | PEG-100 STEARATE, POLYSORBATE-20, ETHYLPARABEN, | |
| One or more animal studies show developmental effects at high doses | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show reproductive effects at high doses | BHT | |
| One or more animal studies show reproductive effects at moderate doses | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show reproductive effects at moderate doses | GLYCERIN, ARGININE | |
| One or more animal studies show any effects at low doses | PROPYLPARABEN | |
| One or more animal studies show any effects at very low doses | BUTYLPARABEN |
Violations, restrictions & warnings*
*This table includes all possible violations, restrictions & warnings concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Determined safe for use in cosmetics, subject to concentration or use limitations - Safe for use in cosmetics with some qualifications | PEG-100 STEARATE, POLYACRYLAMIDE | |
| Recommended restricted in cosmetics - use, concentration, or manufacturing restrictions - Product type restrictions or differences noted in safety assessment by industry panel | DIMETHICONE | |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in some types of cosmetics (concentration limit) | products for use around the eyes; products for use on the lips | OCTINOXATE (OCTYL METHOXYCINNAMATE) |
| Restricted in cosmetics (recommendations or requirements) - use, concentration, or manufacturing restrictions - Japan - restricted for use in some types of cosmetics (concentration limit) | OCTISALATE, PHENOXYETHANOL, NANO ZINC OXIDE (20-60nm) | |
| Violation of government restrictions - Banned or found unsafe for use in cosmetics | METHYLPARABEN |
Neurotoxicity*
*This table includes all possible neurotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show brain and nervous system effects at high doses | ULTRAMARINES, POLYACRYLAMIDE, NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show brain and nervous system effects at moderate doses | PHENOXYETHANOL | |
| One or more animal studies show brain and nervous system effects at high doses | GLYCERIN | |
| One or more animal studies show brain and nervous system effects at low doses | BHT | |
| One or more animal studies show brain and nervous system effects at moderate doses | METHYLPARABEN | |
| One or more animal studies show brain and nervous system effects at very low doses | ARGININE |
Endocrine disruption*
*This table includes all possible endocrine disruption concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show endocrine system disruption at high doses | GLYCERIN | |
| One or more animal studies show endocrine disruption at moderate doses | ISOBUTYLPARABEN | |
| One or more animal studies show endocrine system disruption at high doses | BHT | |
| Human any disruptor - strong evidence | OCTINOXATE (OCTYL METHOXYCINNAMATE), PROPYLPARABEN | |
| One or more animal studies show endocrine disruption at moderate doses | ARGININE | |
| Human any disruptor - strong evidence | METHYLPARABEN, ETHYLPARABEN, BUTYLPARABEN |
Allergies/immunotoxicity*
*This table includes all possible allergies/immunotoxicity concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Limited evidence of skin and immune system toxicity | PHENOXYETHANOL | |
| One or more human case studies show possible immune effects | OCTISALATE, OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Human skin toxicant - strong evidence | TOCOPHERYL ACETATE, PROPYLPARABEN, METHYLPARABEN, ISOBUTYLPARABEN, ETHYLPARABEN, BUTYLPARABEN | |
| Known human immune system toxicant | BHT |
Persistence and bioaccumulation*
*This table includes all possible persistence and bioaccumulation concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Not suspected to be bioaccumulative | POLYACRYLAMIDE | |
| Ingredient is suspected or measured to accumulate in people | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Persistent, bioaccumulative in wildlife | PREZATIDE COPPER ACETATE, NANO ZINC OXIDE (20-60nm) |
Organ system toxicity (non-reproductive)*
*This table includes all possible organ system toxicity (non-reproductive) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show liver effects at high doses (low dose studies may be unavailable for this ingredient) | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| One or more animal studies show kidney or renal system effects at high doses (low dose studies may be unavailable for this ingredient) | ULTRAMARINES, POLYSORBATE-20, PANTHENOL | |
| One or more animal studies show liver effects at moderate doses (low dose studies may be unavailable for this ingredient) | POLYACRYLAMIDE, | |
| One or more animal studies show classified as toxic effects at moderate doses (low dose studies may be unavailable for this ingredient) | NANO ZINC OXIDE (20-60nm) | |
| One or more animal studies show broad systemic effects at moderate doses (low dose studies may be unavailable for this ingredient) | OCTISALATE, TOCOPHERYL ACETATE, GLYCERYL MONOSTEARATE, | |
| One or more animal studies show any effects at moderate doses (low dose studies may be unavailable for this ingredient) | C13-14 ISOPARAFFIN | |
| Limited evidence of sense organ toxicity | PEG-100 STEARATE, PROPYLPARABEN, ISOBUTYLPARABEN, ETHYLPARABEN, BUTYLPARABEN, PREZATIDE COPPER ACETATE | |
| One or more animal studies show blood effects at low doses | BHT | |
| One or more animal studies show sense organ effects at very low doses | products for use around the eyes, mouth, or lips | PHENOXYETHANOL |
| One or more animal studies show cardiovascular effects at very low doses | ARGININE, GLYCERIN | |
| Known human any toxicant | METHYLPARABEN |
Multiple, additive exposure sources*
*This table includes all possible multiple, additive exposure sources concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Designated as safe for general or specific, limited use in food | PEG-100 STEARATE, XANTHAN GUM, TOCOPHERYL ACETATE, PROPYLPARABEN, POLYSORBATE-20, POLYACRYLAMIDE, NANO ZINC OXIDE (20-60nm), METHYLPARABEN, GLYCERYL MONOSTEARATE, GLYCERIN, DIMETHICONE, ARGININE, BHT, BUTYLPARABEN | |
| Used in food or as an additive with limited or no toxicity information available | ULTRAMARINES, PANTHENOL |
Ecotoxicology*
*This table includes all possible ecotoxicology concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Suspected to be an environmental toxin | POLYACRYLAMIDE | |
| Wildlife and environmental toxicity | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Wildlife and environmental toxicity | NANO ZINC OXIDE (20-60nm), PROPYLPARABEN |
Irritation (skin, eyes, or lungs)*
*This table includes all possible irritation (skin, eyes, or lungs) concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show skin irritation at moderate doses | POLYSORBATE-20, NANO ZINC OXIDE (20-60nm), GLYCERIN, BUTYLPARABEN | |
| One or more animal studies show skin irritation at low doses | SQUALANE, OCTISALATE, METHYLPARABEN, BHT | |
| One or more animal studies show skin irritation at very low doses | PEG-100 STEARATE | |
| Classified as irritant | PHENOXYETHANOL |
Data gaps*
*This table includes all possible data gaps concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | PEG-100 STEARATE | |
| Considered safe based on assumption of low absorption | POLYACRYLAMIDE | |
| Insufficient data to determine safety | NANO ZINC OXIDE (20-60nm) | |
| Safety assessment was based on related chemical | ISOBUTYLPARABEN | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | TOCOPHERYL ACETATE | |
| Safety assessment was based on related chemical | PEG-100 STEARATE | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | PHENOXYETHANOL, POLYSORBATE-20, PROPYLPARABEN, DIMETHICONE, ETHYLPARABEN, PANTHENOL, CETEARYL ALCOHOL, GLYCERYL MONOSTEARATE, METHYLPARABEN, BUTYLPARABEN | |
| Not assessed for safety in cosmetics by industry panel | SQUALANE, XANTHAN GUM | |
| Risk assessment method deficiencies and data gaps - Maximum reported "as used" concentration is basis of safety assessment by industry safety panel (Cosmetic Ingredient Review, CIR) - implicit safe concentration limit in product | BHT | |
| Not assessed for safety in cosmetics by industry panel | PREZATIDE COPPER ACETATE, OCTISALATE, NANO ZINC OXIDE (20-60nm), LAURETH-7, GLYCERIN, C13-14 ISOPARAFFIN, ARGININE |
Occupational hazards*
*This table includes all possible occupational hazards concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| Allowed workplace exposures restricted to low doses | BHT, NANO ZINC OXIDE (20-60nm) | |
| Allowed workplace exposures restricted to moderate doses | GLYCERIN | |
| Allowed workplace exposures restricted to low doses | PHENOXYETHANOL |
Biochemical or cellular level changes*
*This table includes all possible biochemical or cellular level changes concerns for the ingredients used by this manufacturer. Some categorizations depend on how the product is used or formulated.
| type of concern | product conditions | ingredient(s) |
| One or more animal studies show biochemical changes at low doses where the human health implications are not yet well understood | BHT | |
| One or more animal studies show biochemical changes at high doses where the human health implications are not yet well understood | ARGININE, GLYCERIN, POLYACRYLAMIDE | |
| Produces excess reactive oxygen species that can interfere with cellular signaling, cause mutations, lead to cell death and may be implicated in cardiovascular disease. | OCTINOXATE (OCTYL METHOXYCINNAMATE) | |
| Interferes with gene expresion | BUTYLPARABEN, METHYLPARABEN | |
| Does not produces excess reactive oxygen species or other harmful biochemical changes. | OCTISALATE |
Copyright © 2010 by Environmental Working Group
All rights reserved.
Favorites basket
No items in basket.
Add this product
Skin Deep User Tools BETA
Looking for a product report that we don't have in Skin Deep? Sign up to enter it into the Skin Deep database and leave product reviews.
SKIN DEEP NEEDS YOUR HELP
We always want Skin Deep to be free to the public, but delivering high-quality research costs time and money. Help by donating just the cost of a bar of soap or bottle of shampoo.
WANT TO KNOW MORE?
Stay informed with email updates on toxics in everyday products and how they can affect your health.
JOIN THE CAMPAIGN
Find out more about the Campaign for Safe Cosmetics.